You are here
Clinical Trials: Wounds and Injuries
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Second- or Third-degree Burns
Intervention: Biological: ALLO-ASCs
Sponsor: A.A. Partners, LLC
Recruiting - verified April 2017
Intervention: Biological: ALLO-ASCs
Sponsor: A.A. Partners, LLC
Recruiting - verified April 2017
Conditions: Osteoarthritis; Rheumatoid Nodule; Degenerative Joint Disease; Tendinopathy; Tendinosis; Back Pain
Interventions: Drug: Normal Saline; Procedure: Tissue Stromal Vascular Fraction; Biological: Platelet Rich Plasma; Procedure: Cellular Stromal Vascular Fraction
Sponsors: Robert W Alexander, MD; Regeneris Medical; Global Alliance for Regenerative Medicine
Recruiting - verified March 2017
Interventions: Drug: Normal Saline; Procedure: Tissue Stromal Vascular Fraction; Biological: Platelet Rich Plasma; Procedure: Cellular Stromal Vascular Fraction
Sponsors: Robert W Alexander, MD; Regeneris Medical; Global Alliance for Regenerative Medicine
Recruiting - verified March 2017
Condition: Acute Kidney Injury
Interventions: Biological: SBI-101; Device: Sham
Sponsor: Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Interventions: Biological: SBI-101; Device: Sham
Sponsor: Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Condition: Spinal Cord Injuries
Intervention: Biological: Autologous Mesenchymal Stem Cells
Sponsor: University of Jordan
Recruiting - verified December 2016
Intervention: Biological: Autologous Mesenchymal Stem Cells
Sponsor: University of Jordan
Recruiting - verified December 2016
Conditions: Endothelial Progenitor Cells; Coronary Artery Disease; Vascular Injury; Coronary Angiography
Intervention: Biological: Administration of radio labelled endothelial outgrowth cells
Sponsors: University of Edinburgh; British Heart Foundation
Recruiting - verified October 2016
Intervention: Biological: Administration of radio labelled endothelial outgrowth cells
Sponsors: University of Edinburgh; British Heart Foundation
Recruiting - verified October 2016
Conditions: Leg Ulcer; Diabetic Foot; Gangrene; Peripheral Vascular Disease; Ischemia
Interventions: Biological: BM-ECs and PRPE; Biological: BM-ECs
Sponsor: South China Research Center for Stem Cell and Regenerative Medicine
Not yet recruiting - verified September 2016
Interventions: Biological: BM-ECs and PRPE; Biological: BM-ECs
Sponsor: South China Research Center for Stem Cell and Regenerative Medicine
Not yet recruiting - verified September 2016
Condition: Bronchopleural Fistula
Intervention: Biological: UCMSC
Sponsors: The Second Affiliated Hospital of Fujian Medical University; Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Recruiting - verified November 2016
Intervention: Biological: UCMSC
Sponsors: The Second Affiliated Hospital of Fujian Medical University; Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Recruiting - verified November 2016
Condition: Chronic Nasal Septum Perforation
Intervention: Biological: Collagen membrane + HUC-MSCs
Sponsors: Chinese Academy of Sciences; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting - verified October 2016
Intervention: Biological: Collagen membrane + HUC-MSCs
Sponsors: Chinese Academy of Sciences; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting - verified October 2016
Conditions: Corneal Injuries; Corneal Burns; Corneal Scars and Opacities
Intervention: Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor: L.V. Prasad Eye Institute
Recruiting - verified October 2016
Intervention: Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor: L.V. Prasad Eye Institute
Recruiting - verified October 2016
Condition: Humerus Fracture Displaced Proximal
Interventions: Biological: BMC2012; Device: beta-TCP
Sponsors: Goethe University; LOEWE CGT
Not yet recruiting - verified June 2016
Interventions: Biological: BMC2012; Device: beta-TCP
Sponsors: Goethe University; LOEWE CGT
Not yet recruiting - verified June 2016
